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Objective: Islet transplantation is one of the possible solutions to cure type 1 
diabetes. Now clinical islet transplant’s regiment which based on the Edmonton 
protocol has been a great success, Many patients with type 1 diabetes do not have 
daily injections of insulin. However, most patients still can not keep the normal blood 
sugar levels in long time after islet transplantation.And transplantation 
immunosuppressant also have toxic side effects.In addition, the development of islet 
transplantation is also seriously limited by the shortage of human donor. Although 
xenogeneic islet cells can achieve an adequate supply, compared with allograft, 
xenograft transplant immune rejection more intense, and exclusion mechanism more 
complex. now xenotransplantation immune rejection mechanisms are not yet fully 
clear. Allograft immunosuppressant can not be applied directly to xenotransplantation. 
Therefore, to developed new immunosuppressant for xenotransplantation, become an 
important issue to be solved. 
METHODS: We used STZ in C57BL / 6 mice to induced type 1 diabetes. Then we 
establishment the islet xenograft model with LEWIS rats to C57BL/6 mice. 
Accordance with different regimen，the mice divided into four groups, namely 
“CONTROL”group(without medication),“Lef”group(leflunomide,10mg/kg/d), 
“As”group(As2O3,5mg/kg/d), and“Lef+As”group(LEF,10mg/kg/d;As2O3,5mg/kg/
d),Finally,We analyze the vivo and vitro data for each group, in order to study the role 
of As2O3 in islet xenograft model。 
Results: The median survival in the As group was 13 days, compared with the 
CONTROL group’s  8 days, extension five days. Graft site: As group CD4+T, CD8+ 
T cell levels, and IL-2, IL-4, IFN-γ levels lower then CONTROL group, Foxp3 + and 
TGF-β levels higher then CONTROL group. Lymph node: As group CD4+T, CD8 + T 
cell ratio lower than CONTROL group, Foxp3+Treg ratio is higher than CONTROL 
group. Spleen: CD4 + T, CD8 + T cell ratio lower than CONTROL group, the 
absolute number of B cells is less than CONTROL group. Sera: As group IL-2, IL-4, 
IFN-γ, IgM, IgG2a levels lower then CONTROL group. Lef+As group in this 















group IL-2, IFN-γ, IgM, IgG2a, IgG have lowest level and Foxp3+and TGF-β levels 
was the highest in the experiment. the Differences data between the groups have 
statistically significant (P <0.05). 
Conclusion: As2O3 by reducing cell transplantation immunity, improve Foxp3 + 
regulatory T cells, and reduce serum part of antibody levels to prolong survival of 
islets graft. Arsenic trioxide combined with leflunomide have synergistic effect. 

































































3.1.2  胰岛移植功能及活性 27.....................................................................
3.2  移植部位受到的免疫排斥⽔水平检测 29...............................
3.2.1  病理学检测 29....................................................................................
3.2.2  免疫因⼦子检测 31................................................................................
3.2.3  淋巴细胞浸润检测 31.........................................................................
3.3  脾脏与淋巴结的T淋巴细胞检测 33....................................
3.3.1 淋巴细胞分型检测 33..........................................................................
3.3.2  ⾎血清中细胞因⼦子及Th1 Th2细胞⽐比例检测 34......................................
3.4 不同⽤用药组间调节性T细胞检测 36.....................................



























                                                                
                                         Table of Contents
Abstract……………………………………………………….V
Chapter I Introduction …………………………….….……….1
1.1 islet transplantation ……………………………….………………2
     1.2 xenotransplantation .………………….…………………………..2
          1.2.1 hyperacute rejection …………………………………………3
          1.2.2 Delayed xenograft rejection ………………………….……. 4
          1.2.3 cellular rejection ………………………..…………………… 4
            1.2.4. Chronic rejection ……………………..……….……………. 4
   1.3 clinical immunosuppressant plan …………….………………. 4
          1.3.1 Zenapax …………………………………….…………………4
          1.3.2 FK506 ………………………………………………………… 5
          1.3.3 rapamycin .......................................……………………….. 5
    1.4 leflunomide …………………………….………..…………..…….. 5
          1.4.1 mechanism of leflunomide ………………………………… 6
1.5 Arsenic trioxide …………………….………………………………7
1.6 Research purpose and meaning ..……………..………………. 8
Chapter II Materials and Methods …………………………. 10
     2.1 Experimental Materials ………………………………………… 10
          2.1.1 Laboratory Animal ............................................................ 10
          2.1.2 Laboratory Instrument ...................................................... 10
2.1.3 Reagents .......................................................................... 10
2.2 Methods …………..………………………………………………. 12















2.2.2 DTZ transfer color ………………………………………….….13
2.2.3 islet cell activity …………….……………………………….… 13
2.2.4 Diabetic Mouse Model ……………….………..………………14
2.2.5 islet transplantation ……….…………….……………………. 14
2.2.6 regimen ..…………………………………..………….………. 15
2.2.7 cellular immunology research Remedies ……….…………..16
2.2.8 Methodology of Molecular Research ……………….…….….20
2.3 Statistical analysis ……….……………………….…….………. 25
Chapter III Results and discussion …………………..…… 27
3.1 difference between survival and insulin activity …..……… 27
3.1.1 islet transplantation survival ………………………..….…… 27
3.1.2 islet function and activity ……………………………….…….28
3.2 immune rejection………………….……….……………….…… 30
3.2.1 pathologic examination ………………………………….….. 30
3.2.2 Cytokines……………………………………….………………32
3.2.3 lymphocytic infiltration detection …………………………….32
3.3 spleen and lymph node of T lymphocyte detection..…..…..34
3.3.1 lymphocytes genotyping ……………….…………………… 34
3.3.2 serum cytokines and Th1 Th2 cell ratio detection ............. 35
3.4 Regulatory T Cells…………………………………..………….. 37
3.4.1 Foxp3+Treg  ratio and immune factors detection .………..37
 3.5 B cell and antibody detection.……….……..………………….38
3.5.1 B cells ratio and absolute number detection ……………….38
3.5.2 serum antibody detection.………………………..………….. 39















4.1 Conclusion …………………………………………………….. 40


















































































































































































Degree papers are in the “Xiamen University Electronic Theses and 
Dissertations Database”.  
Fulltexts are available in the following ways: 
1. If your library is a CALIS member libraries, please log on 
http://etd.calis.edu.cn/ and submit requests online, or consult the interlibrary 
loan department in your library. 
2. For users of non-CALIS member libraries, please mail to etd@xmu.edu.cn 
for delivery details. 
厦
门
大
学
博
硕
士
论
文
摘
要
库
